Orexigen Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 132

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 13

  • Investments
  • 1

Orexigen Therapeutics General Information

Description

Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3344 North Torrey Pines Court
  • Suite 200, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 3344 North Torrey Pines Court
  • Suite 200, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orexigen Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orexigen Therapeutics‘s full profile, request access.

Request a free trial

Orexigen Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older dru
Pharmaceuticals
San Diego, CA
132 As of 2018

Tarrytown, NY
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orexigen Therapeutics Competitors (35)

One of Orexigen Therapeutics’s 35 competitors is Regeneron Pharmaceuticals, a Formerly VC-backed company based in Tarrytown, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
Pfizer (Vienna) Corporation Vienna, Austria
TG Therapeutics Corporation Morrisville, NC
Pfizer Pakistan Corporation Karachi, Pakistan
Vericel Formerly PE-Backed Burlington, MA
You’re viewing 5 of 35 competitors. Get the full list »

Orexigen Therapeutics Patents

Orexigen Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020037593-A Compositions and methods for reducing major adverse cardiovascular events Active 06-Dec-2013
WO-2015085044-A1 Compositions and methods for reducing major adverse cardiovascular events Inactive 06-Dec-2013
JP-2026088122-A Method of treating overweight and obesity Pending 06-Jun-2012
JP-2018158945-A Methods of treating overweight and obesity Active 06-Jun-2012
JP-2021080274-A Methods of treating overweight and obesity Pending 06-Jun-2012 A61K31/485
To view Orexigen Therapeutics’s complete patent history, request access »

Orexigen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orexigen Therapeutics Investments (1)

Orexigen Therapeutics’s most recent deal was a Corporate Asset Purchase with Contrave (US rights) for . The deal was made on 15-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Contrave (US rights) 15-Mar-2016 Corporate Asset Purchase Pharmaceuticals
To view Orexigen Therapeutics’s complete investments history, request access »

Orexigen Therapeutics FAQs

  • When was Orexigen Therapeutics founded?

    Orexigen Therapeutics was founded in 2002.

  • Where is Orexigen Therapeutics headquartered?

    Orexigen Therapeutics is headquartered in San Diego, CA.

  • What is the size of Orexigen Therapeutics?

    Orexigen Therapeutics has 132 total employees.

  • What industry is Orexigen Therapeutics in?

    Orexigen Therapeutics’s primary industry is Pharmaceuticals.

  • Is Orexigen Therapeutics a private or public company?

    Orexigen Therapeutics is a Private company.

  • What is the current valuation of Orexigen Therapeutics?

    The current valuation of Orexigen Therapeutics is .

  • What is Orexigen Therapeutics’s current revenue?

    The current revenue for Orexigen Therapeutics is .

  • How much funding has Orexigen Therapeutics raised over time?

    Orexigen Therapeutics has raised $379M.

  • Who are Orexigen Therapeutics’s competitors?

    Regeneron Pharmaceuticals, Pfizer (Vienna), TG Therapeutics, Pfizer Pakistan, and Vericel are some of the 35 competitors of Orexigen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process